Unveiling the Complex Role of Exosomes in Alzheimer's Disease
Mingyue Sun,Zhuoyou Chen
DOI: https://doi.org/10.2147/jir.s466821
IF: 4.5
2024-06-19
Journal of Inflammation Research
Abstract:Mingyue Sun, Zhuoyou Chen Department of Neurology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, 213000, People's Republic of China Correspondence: Zhuoyou Chen, Email Alzheimer's disease (AD) is the most common neurodegenerative illness, characterized by memory loss and cognitive decline, accounting for 60– 80% of dementia cases. AD is characterized by senile plaques made up of amyloid β (Aβ) protein, intracellular neurofibrillary tangles caused by hyperphosphorylation of tau protein linked with microtubules, and neuronal loss. Currently, therapeutic treatments and nanotechnological developments are effective in treating the symptoms of AD, but a cure for the illness has not yet been found. Recently, the increased study of extracellular vesicles (EVs) has led to a growing awareness of their significant involvement in neurodegenerative disorders, including AD. Exosomes are small extracellular vesicles that transport various components including messenger RNAs, non-coding RNAs, proteins, lipids, DNA, and other bioactive compounds from one cell to another, facilitating information transmission and material movement. There is growing evidence indicating that exosomes have complex functions in AD. Exosomes may have a dual role in Alzheimer's disease by contributing to neuronal death and also helping to alleviate the pathological progression of the disease. Therefore, the primary aim of this review is to outline the updated understandings on exosomes biogenesis and many functions of exosomes in the generation, conveyance, distribution, and elimination of hazardous proteins related to Alzheimer's disease. This review is intended to provide novel insights for understanding the development, specific treatment, and early detection of Alzheimer's disease. Keywords: Alzheimer's disease, exosomes, pathogenesis, diagnosis, treatment Alzheimer's disease (AD), commonly referred to as senile dementia, is a common central neurodegenerative disorder. AD primarily manifests as a slow reduction in self-care abilities, increasing memory loss, and cognitive impairment, along with neuropsychiatric disorders, significantly impacting the quality of life of patients. 1 AD accounts for over 60% of dementia cases. Sporadic cases account for over 90% of cases. The disease progresses through memory and cognitive disabilities, causing mood swings, agitation, irritability, and reduced vital functions. 2–4 Amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) are key factors in Alzheimer's disease (AD) pathophysiology. 5 These plaques form when extracellular Aβ monomers are handled by secretases, leading to inflammatory response and damaging neurons. 6 Defective hyperphosphorylation as well as incorrectly folded tau also produce intracellular NFTs, impairing neuronal signal. 7 The researchers have dedicated significant resources to investigate etiology of AD, but it remains incompletely understood, and there is now no viable medication to halt the progression of AD. Food and Drug Administration (FDA)-approved drugs do not provide a definitive therapy for the pathophysiology of AD, but they do give symptomatic relief by slowing down the course of the disease. Treatment for Alzheimer's disease often involves targeting the increase of Acetylcholine levels to avoid its degradation, hence protecting memory and cognitive abilities. 8 Recent advancements in therapy, such as disease-modified AD medications, have been developed to overcome the limitations of traditional treatments. This technique requires a thorough understanding of metabolic pathways and utilizes several targeted tactics to provide effective medicine. 5 As research on extracellular vesicles (EVs) advances, it has become evident that a specific kind of tiny EVs known as exosomes are significant in the pathogenic process of AD. Exosomes are nanosized extracellular vesicles released upon the exocytosis of a MVB, characterized by a bilayer membrane structure. Exosomes may be secreted by the majority of cell types and are often found in bodily fluids. 9 Exosomes in the central nervous system (CNS) transmit messages locally inside cells and extensively across the brain via the cerebrospinal fluid (CSF). 10 Exosomes, containing proteins, lipids, and nucleic acid molecules, are transported from donor cells to distant recipient cells through mechanisms like phagocytosis, pinocytosis, endocytosis, or plasma membrane fusion, containing specific cargoes. 11 Additionally, exosomes are seen as carrier vehicles that may travel actively between cells, facilitating material and information exchange. Research indicates several cells within the CNS, such as neurons, astrocytes, oligodendrocytes, microglia, and endothelial cells, are capable -Abstract Truncated-
immunology